Kedrion S.p.A. has achieved the international PAS 24000 Certification, further strengthening its commitment to a model of social responsibility that is deeply embedded in its mission and guided by its corporate Values. This milestone represents a natural evolution from the SA8000 Standard, adopted in 2004, toward a more modern framework aligned with ESG principles and the UN 2030 Agenda for Sustainable Development.
In the biopharmaceutical sector, social responsibility is shifting from a reactive, compliance-based approach to a strategic and long-term vision. Kedrion is at the forefront of this transformation, integrating sustainability into its operations and promoting ethical governance, inclusivity, and equitable access to medicines.
The PAS 24000 standard is fully aligned with Kedrion’s vision and strategy. Like SA8000, it places strong emphasis on workers’ rights and health & safety, while also addressing broader themes such as human rights, business ethics, and anti-corruption.
“This certification is not just a recognition, it’s a declaration of intent” said Nicola Galtieri, Head of Global Ethics & Compliance. “It confirms our commitment to embedding social responsibility into every aspect of our business, from internal culture to external partnerships.”
At Kedrion, we recognize the right to health – for both donors and patients – as a fundamental human right. Improving access to new therapies in different countries is part of this responsibility.
This certification is not an endpoint, but an important milestone for an even broader engagement. It reinforces our responsibility to lead by example – within our company and across our supply chain, from plasma collection to the production of therapies – by promoting a culture of integrity, inclusion, and shared value.
In this spirit, the PAS 24000 Certification, obtained by Kedrion in Italy, serves as a benchmark for all companies within the Group. Our commitment to social responsibility is shared globally and reflected throughout our entire organization.